Related Experiment Video
Updated: May 16, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Practical recommendations for the management of children with endemic Burkitt lymphoma (BL) in a resource limited
Peter Hesseling1, Trijn Israels, Mhamed Harif
1Department of Paediatrics and Child Health, University of Stellenbosch, Cape Town, South Africa. pbh@sun.ac.za
Insights
Treatment guidelines for endemic Burkitt lymphoma (BL) in resource-limited settings are proposed. These recommendations aim to improve cure rates, which are typically below 50% for this pediatric cancer.
Area of Science:
- Oncology
- Pediatric Hematology-Oncology
- Global Health
Background:
- Endemic Burkitt lymphoma (BL) presents a significant challenge in low-resource settings, with cure rates often below 50% due to limited treatment capabilities.
- Treatment protocols need adaptation for facilities with minimal requirements for curative care (PODC setting 1), where healthcare infrastructure varies considerably.
Purpose of the Study:
- To develop evidence-based treatment recommendations for endemic Burkitt lymphoma (BL) tailored to resource-constrained environments.
- To provide distinct therapeutic strategies addressing different clinical scenarios, including the inability to perform accurate staging and cases of relapse or poor response.
Main Methods:
- A comprehensive literature review was conducted to gather existing data on BL treatment efficacy.
- Personal clinical experience from managing BL in PODC setting 1 was integrated to refine treatment protocols.
Main Results:
- Three distinct treatment schedules were formulated: one for non-staged disease, one for staged disease, and a rescue regimen for relapsed/refractory cases.
- The 1-year event-free survival rates were recorded as 48% for treatment 1, 61% for treatment 2, and 35% for the rescue treatment.
Conclusions:
- The proposed treatment recommendations offer a structured approach to managing endemic Burkitt lymphoma in settings with minimal curative care capabilities.
- These guidelines aim to optimize outcomes and improve survival rates for children and adults with BL in resource-limited regions.
Abstract:
Treatment recommendations for endemic Burkitt lymphoma (BL) in settings with only minimum requirements for curative treatment (PODC setting 1) are described. The reported cure rate for endemic BL is usually <50%. Facilities within setting 1 differ. Three treatment schedules are proposed based on: (1) when accurate staging is not possible, (2) when staging is possible and for (3) relapses and poor responders to primary therapy. A literature review and personal experience were used to formulate the recommendations. Recorded 1-year event free survival was 48% for treatment 1, 61% for treatment 2, and 35% for the rescue treatment.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
